期刊文献+

降钙素原联合APACHE Ⅱ评分对脓毒症病情及预后判断的指导价值 被引量:1

The Guiding Value of Procalcitonin and APACHEⅡ Score for Prognosis of Sepsis
下载PDF
导出
摘要 目的探讨血清降钙素原(PCT)检测联合APACHE Ⅱ评分对脓毒症病情及预后的价值。方法对长沙市第四医院重症医学科68例脓毒症患者按疾病的严重程度分为脓毒症组、严重脓毒症组、脓毒性休克组,分别检测各组血清PCT,并同时进行APACHE Ⅱ评分,对PCT与APACHE Ⅱ进行相关性分析。然后再根据患者转归不同分为生存组和死亡组,评价PCT、APACHE Ⅱ评分对脓毒症预后的判断的指导价值。结果脓毒症组PCT低于严重脓毒症组,严重脓毒症组PCT低于脓毒性休克组,其差异均具有统计学意义(P<0.05),死亡组PCT及APACHE Ⅱ评分明显高于生存组,差异具有统计学意义(P<0.05)。结论脓毒症患者PCT水平与APACHE Ⅱ评分具有相关性;检测PCT水平联合APACHE Ⅱ评分对脓毒症病情及预后判断具有指导价值。 Objective To investigate the value of serum procalcitonin (PCT) detection combined with APACHE Ⅱ score for the prognosis of patients with sepsis. Methods A total of 68 patients with sepsis in the ICU(Intensive Care Unit)of the Fourth Hospital in Changsha were divided into three groups according to clinical severity: early sepsis group, severe sepsis group and septic shock group. For septic patients in each group, serum PCT values were detected, APACHEⅡ scores were calculated simultaneously, and the correlations between PCT and APACHEⅡ were analyzed. Then patients were divided into survival group and death group according to their different outcomes, to evaluate the guiding value of PCT and APACHE Ⅱ score for prognosis of sepsis. Results The PCT values in early sepsis group were obviously below that in severe group, and PCT values in severe group were obviously below that in septic shock group, the differences were statistically significant(P〈0.05), moreover, the PCT and APACHEⅡ scores of death group were significantly higher than that of survival group, the difference was statistically significant (P 〈0.05) Conclusion The PCT levels of patients with sepsis and their APACHEⅡ scores are correlated; It is valuable to detect the PCT levels combined with APACHEⅡ scores for the prognosis of patients with sepsis.
作者 夏凤强
出处 《中国医药指南》 2014年第15期31-32,共2页 Guide of China Medicine
关键词 脓毒症 降钙素原 APACHE Ⅱ评分 Sepsis Procalcitonin(PCT) APACHEⅡ score
  • 相关文献

参考文献8

  • 1HatheM,Tibby SM,Turner C,et a1.Procalcitonin and cytokine levels: relationship to organ failure and mortality in pediatric septic shock[J].Cfit Care Med,2000,28(7):2591-2594.
  • 2Russwurm S,Wiederhold M,Oberhoffer M.Molecular aspects and natural source of procalcitonin[J].Clin Chem Lab Med,1999,37(8):789-797.
  • 3Becker K L,Snider R,Nylene S.Procalcitonin assay in systemic inflammation,infection,and sepsis:clinical utility and limitations[J].Critical Care Med,2008,36(3):941-952.
  • 4oh,TE,Hutchinson R,Short S,et a1.Verification of the Acute Physiology and Chronic Health Evaluation scoring system in a Hong Kong intensive care unit[J].Crit Care Med,1993,21(5):698-705.
  • 5Manma P,Nedelnikova K,Gurlich R.Physiology and genetics of procaleitonin[J].Physiol Res,2000,49(1):s57-61.
  • 6吴丽娟,鲁涛,尹培刚,陈德生,陈福成.脓毒血症患者血浆降钙素原的变化及其意义[J].中日友好医院学报,2004,18(2):73-76. 被引量:31
  • 7LuzzaniA,PolatiE,DorizziR,et al.Comparison of procalcitonin and reactive protein as markers of sepsis[J].Crit Care Med,2003,31(6):1737-1741.
  • 8梁建业.第3代危重患者病情评价系统——APACHE、SAPSⅡ和MPMⅡ[J].中国危重病急救医学,2000,12(4):249-253. 被引量:53

二级参考文献11

  • 1梁建业.危重病患者病情评定法——APACHE系统的研究进展[J].中国危重病急救医学,1996,8(1):52-56. 被引量:65
  • 2[2]Brunkhorst FM,Wegscheider K,Forychi ZF,et al.Procalcitonin for early diagnosis and differentiation of SIRS,sepsis,severe sepsis,and septic shock[J].Intensive Care Med,2000,26(Suppl 2):148-152.
  • 3[3]Eberhard OK,Langefeld I,Kuse ER,et al.Procalcitonin in the early phase after renal transplantation -will it add to diagnostic accuracy[J]? Clin Transplant,1998,12(3):206-211 .
  • 4[4]Brunkhorst FM,Eberhard OK,Brunkhorst R,et al.Discrimination of infectious and non-infectious causes of early acute respiratory distress syndrome by procalcitonin[J].Crit Care Med,1999,27(10):2172-2176.
  • 5[5]American College of Chest Phsicians/Society of Critical Care Medicine Consensus Conference:Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis[J].Crit Care Med,1992,20(6):864-874.
  • 6[6]Knaus WA,Draper EA,Wagner DP,et al.APACHEⅡ:A severity of disease classification system[J]. Crit Care Med,1985,13(10):818-829.
  • 7[7]Oberhoffer M,Ruwurm S,Bredle D,et al.Discriminative power of inflammatory markers for prediction of tumor necrosis factor-αand interleukin-6 in ICU patients with systemic inflammatory response syndrome(SIRS) or sepsis at arbitrary time points[J].Intensive Care Med,2000,26(Suppl 2):170-174.
  • 8[8]Meisner M,Tschaikowsky K,Palmaers T,et al.Procalcitonin and CRP inseptic shock:inflammatory parameters with different kinetics[J].Intensive Care Med,1996,22(Suppl 1):14.
  • 9[9]Reith HB,Mittelkotter U,Wagner R,et al.Procalcitonin(PCT) in patients with abdominal sepsis[J]. Intensive Care Med,2000,26(Suppl 2):165-169.
  • 10[10]Brunkhorst FK,Heinz U,Forycki ZF.Kinetics of procalcitonin in iatrogenic sepsis[J]. Intens Care Med,1998,24(8):888-892.

共引文献81

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部